Widening for clopidogrel BE study [Outliers]

posted by mittyri – Russia, 2021-06-16 18:04 (1066 d 14:29 ago) – Posting: # 22419
Views: 4,168

Dear Loky do

❝ is widening of Cmax accepted in clopidogrel BE studies with fully replicate design or not?


You linked the EMA Q&A where it is stated unequivocally:
Under these circumstances, the widening of 90% confidence intervals for Cmax is not recommended.

Kind regards,
Mittyri

Complete thread:

UA Flag
Activity
 Admin contact
23,029 posts in 4,834 threads, 1,641 registered users;
28 visitors (0 registered, 28 guests [including 7 identified bots]).
Forum time: 08:34 CEST (Europe/Vienna)

The most erroneous stories are those we think we know best–
and therefore never scrutinize or question.    Stephen Jay Gould

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5